Abstract:ObjectivesThe proarrhythmic risk of QT prolonging drugs varies significantly. However, the mechanisms responsible for the high or low risk of drug-induced arrhythmias remain unknown. In this study, we tested our hypothesis that a proarrhythmic window exists for drugs that block multiple ion channels, which may be a cause of drugs with a high or low risk of proarrhythmia. Based on date from single cell research, tolterodine (a bladder inotropic drug), amiodarone and ranolazine are used as multiple channel inhibitors.MethodsHearts from New Zealand White female rabbits weighing 2.5-3.5 kg were isolated, perfused in a Langendorff mode with modified Krebs-Hensileit solution. The atrioventricular nodal area was thermally ablated to produce complete atrioventricular block, and then heart was paced at a frequency of 1 Hz. Multiple channel monophasic action potentials (MAP) and pseudo 12-lead electrocardiograms (ECGs) were recorded. MAPD90 and transmural dispersion of repolarization (TDR) were measured.ResultsIn the absence of a drug (control), MAPD90s recorded from epicardium and endocardium of left ventricule were 186.5 ± 5.5 and 206.5 ± 5.1 ms (n = 8), respectively. Administration of tolterodine from 10 nM to 600 nM, MAPD90 was increased, in concentration dependent manners, from 196.7.0 ± 4.9 to 281.7 ± 26.8 ms, and 220.0 ± 4.6 ms to 350.6 ± 18.7 ms (n = 8, p < 0.001 vs control), respectively. However, when the concentration of tolterodine increased to 10 µM from 600 nM, MAPD90 was decreased to 224.2 ± 5.9 and 252.5 ± 5.9 ms (n = 8), respectively. In addition, the incidence of TdP was correlated with the biphasic changes of MAPD90. Polymorphic ventricular tachycardias (PVT) were recorded at concentrations of 0.1-1 µM. There was no arrhythmia in the presence of 100-600 nM and 3-10 µM tolterodine. In contrast, amiodarone caused PVT only at 0.03-0.3 µM in the presence of late INa enhancer ATX-II. Ranolazine prolonged MAPD90 in absence, but not in the presence of ATX-II and caused no PVT.ConclusionsThe biphasic pattern of MAPD induced by tolterodine, as well as by amiodarone and ranolazine, suggests that a proarrythmic window exists in multiple ion channel blockers, which may be a determinator of the risk of drug-induced proarrhythmias. The mechanism of the biphasic change may be attributed to the relative selectivity of drug on IK and late INa.

Effect of four 5-hydroxytryptamine type 4 receptor agonists on rat cardiac Iκ1 channels and proarrhythmic risk stratification

Electrophysiologic Study of the Biphasic Effects of Cyclovirobuxine D on Arrhythmias

Zacopride Exerts an Antiarrhythmic Effect by Specifically Stimulating the Cardiac Inward Rectifier Potassium Current in Rabbits: Exploration of a New Antiarrhythmic Strategy

Drug Toxicity on Cardiac Pacemaking: a Multi-Scale Modelling Study.

Design, Synthesis, and Negative Inotropic Evaluation of 4‐phenyl‐1h‐1,2,4‐triazol‐5(4h)‐one Derivatives Containing Triazole or Piperazine Moieties

Effects of mBzR inhibition on APD90 and EEP of ischemic cardiomyocytes in rat

Zacopride stimulates 5-HT4 serotonin receptors in the human atrium

Effect of antihistaminic agents on the ATP-sensitive potassium channel activity in isolated mouse ventricular cardiomyocytes

Design, Synthesis and Biological Evaluation of 4-Chromanone Derivatives As I-Kr Inhibitors

Effect of Tetramethyl Pyrazine on L-type Calcium Channel in Rat Ventricular Myocytes

Blockade of Voltage‐Gated K+ Channels in Rabbit Coronary Arterial Smooth Muscle Cells by the Antipsychotic Drug Zotepine

Effects of Cilostazol on the Mrna Expression of Kv4. 3 Gene in Neonatal Rat Ventricular Myocytes

Mosapride stimulates human 5-HT4-serotonin receptors in the heart

GW24-e2999 Proarrhythmic window of a drug determines the risk of multiple ion channel inhibitors

Modulating the voltage sensor of a cardiac potassium channel shows antiarrhythmic effects

Electrophysiological Mechanism of Catestatin Antiarrhythmia: Enhancement of Ito, IK, and IK1 and Inhibition of ICa-L in Rat Ventricular Myocytes

Proarrhythmic effects induced by benzethonium chloride and domiphen bromide in vitro and in vivo

How to Determine Cardiac Ion Channels Targeted by Drugs Using the Isolated Rabbit Ventricular Wedge Model

Studies on Ionic Mechanisms of the Effects of Isoproterenol on Brugada Syndrome

Effect of Wenxin Keli and quinidine to suppress arrhythmogenesis in an experimental model of Brugada syndrome

Proarrhythmic and Antiarrhythmic Effects of Multiple Ion Channel Inhibitors Modulated by the Late Sodium Current